XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.21.2

EARNINGS (LOSS) PER SHARE INFORMATION | 9 Months Ended
--- | ---
Sep. 30, 2021
EARNINGS (LOSS) PER SHARE INFORMATION |
EARNINGS (LOSS) PER SHARE INFORMATION | NOTE 4 – EARNINGS (LOSS) PER SHARE INFORMATION ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months | ​ | For the Nine Months | ​
​ | ​ | Ended September 30, | ​ | Ended September 30, | ​
​ |  | 2021 |  | 2020 |  | 2021 |  | 2020 | ​
Net Income (Loss) | ​ | $ | 14,163,934 | ​ | $ | (1,961,603) | ​ | $ | (20,789,318) | ​ | $ | (93,157,551) | ​
Basic Weighted-Average Shares Outstanding | ​ |  | 99,358,504 | ​ | ​ | 67,980,961 | ​ |  | 99,251,532 | ​ |  | 67,985,168 | ​
Effect of dilutive securities: | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​ | ​
Stock options | ​ |  | 135,536 | ​ | ​ | — | ​ |  | — | ​ |  | — | ​
Restricted stock | ​ |  | 1,463,690 | ​ | ​ | — | ​ |  | — | ​ |  | — | ​
Common warrants | ​ | ​ | 20,263,018 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​
Diluted Weighted-Average Shares Outstanding | ​ |  | 121,220,748 | ​ | ​ | 67,980,961 | ​ |  | 99,251,532 | ​ |  | 67,985,168 | ​
Basic Earnings (Loss) per Share | ​ | $ | 0.14 | ​ | $ | (0.03) | ​ | $ | (0.21) | ​ | $ | (1.37) | ​
Diluted Earnings (Loss) per Share | ​ | $ | 0.12 | ​ | $ | (0.03) | ​ | $ | (0.21) | ​ | $ | (1.37) | ​
​ Stock options to purchase 70,500 share of common stock and 14,709 share of unvested restricted stock were excluded from the computation of diluted earnings per share during the three months ended September 30, 2021. Stock options to purchase 465,500 shares of common stock, 3,247,623 shares of unvested restricted stock and unexercised common warrants of 29,519,500 were excluded from the computation of diluted earnings per share during the nine months ended September 30, 2021, as their effect would have been anti-dilutive. Stock options to purchase 483,500 shares of common stock and 1,326,709 shares of unvested restricted stock were excluded from the computation of diluted earnings per share during both the three and nine months ended September 30, 2020, as their effect would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration